Creative Director / print / digital

BLOCKING ESTROGEN 24/7. This HCP campaign introduces a new updated SERD with better bioavailability that blocks Estrogen 24/7 in the treatment of breast cancer. SERD (Selective Estrogen Receptor Degrader) class, is one of the most effective approaches to treating ER+/HER2 - advanced metastatic breast cancer.